Citadel Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-528,400
| Closed | -$44.9M | – | 11881 |
|
|
2020
Q3 | $44.9M | Buy |
528,400
+76,600
| +17% | +$3.87M | 0.01% | 936 |
|
|
2020
Q2 | $16M | Buy |
451,800
+239,700
| +113% | +$7.01M | 0.01% | 1702 |
|
|
2020
Q1 | $2.86M | Sell |
212,100
-187,200
| -47% | -$3.15M | ﹤0.01% | 3538 |
|
|
2019
Q4 | $8.45M | Buy |
399,300
+66,100
| +20% | +$1.17M | ﹤0.01% | 2400 |
|
|
2019
Q3 | $4.42M | Buy |
333,200
+178,800
| +116% | +$2.63M | ﹤0.01% | 3278 |
|
|
2019
Q2 | $2.14M | Sell |
154,400
-56,300
| -27% | -$847K | ﹤0.01% | 4406 |
|
|
2019
Q1 | $4.05M | Sell |
210,700
-274,400
| -57% | -$4.42M | ﹤0.01% | 3289 |
|
|
2018
Q4 | $6.92M | Buy |
485,100
+170,600
| +54% | +$3.39M | ﹤0.01% | 2348 |
|
|
2018
Q3 | $6.55M | Sell |
314,500
-15,300
| -5% | -$362K | ﹤0.01% | 2632 |
|
|
2018
Q2 | $7.81M | Buy |
329,800
+96,300
| +41% | +$1.94M | ﹤0.01% | 2202 |
|
|
2018
Q1 | $3.41M | Sell |
233,500
-108,700
| -32% | -$1.78M | ﹤0.01% | 2963 |
|
|
2017
Q4 | $5.53M | Buy |
342,200
+121,700
| +55% | +$1.44M | ﹤0.01% | 2366 |
|
|
2017
Q3 | $3.08M | Buy |
220,500
+102,600
| +87% | +$1.02M | ﹤0.01% | 2886 |
|
|
2017
Q2 | $1.04M | Buy |
117,900
+13,500
| +13% | +$94.8K | ﹤0.01% | 4025 |
|
|
2017
Q1 | $675K | Buy |
104,400
+13,400
| +15% | +$67.9K | ﹤0.01% | 4558 |
|
|
2016
Q4 | $334K | Buy |
91,000
+4,900
| +6% | +$14.5K | ﹤0.01% | 5530 |
|
|
2016
Q3 | $280K | Sell |
86,100
-19,500
| -18% | -$54.5K | ﹤0.01% | 5789 |
|
|
2016
Q2 | $245K | Buy |
105,600
+42,500
| +67% | +$142K | ﹤0.01% | 5514 |
|
|
2016
Q1 | $158K | Sell |
63,100
-63,700
| -50% | -$143K | ﹤0.01% | 5797 |
|
|
2015
Q4 | $389K | Buy |
126,800
+4,000
| +3% | +$11.2K | ﹤0.01% | 4824 |
|
|
2015
Q3 | $211K | Sell |
122,800
-50,400
| -29% | -$129K | ﹤0.01% | 6077 |
|
|
2015
Q2 | $703K | Buy |
173,200
+56,500
| +48% | +$231K | ﹤0.01% | 4464 |
|
|
2015
Q1 | $447K | Buy |
116,700
+18,400
| +19% | +$80K | ﹤0.01% | 5069 |
|
|
2014
Q4 | $472K | Buy |
98,300
+5,000
| +5% | +$19.8K | ﹤0.01% | 4809 |
|
|
2014
Q3 | $347K | Buy |
93,300
+10,700
| +13% | +$36.2K | ﹤0.01% | 5086 |
|
|
2014
Q2 | $301K | Buy |
82,600
+700
| +0.9% | +$2.57K | ﹤0.01% | 5068 |
|
|
2014
Q1 | $345K | Sell |
81,900
-161,100
| -66% | -$799K | ﹤0.01% | 4857 |
|
|
2013
Q4 | $1.12M | Buy |
243,000
+19,500
| +9% | +$86.8K | ﹤0.01% | 3123 |
|
|
2013
Q3 | $1.38M | Buy |
223,500
+39,600
| +22% | +$228K | ﹤0.01% | 2770 |
|
|
2013
Q2 | $1M | Buy |
+183,900
| New | +$604K | ﹤0.01% | 3189 |
|
Citadel Advisors's IMMU Position: Q4 2020 in Review
Citadel Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,506,602 shares — an estimated $213M sold.
Citadel Advisors first reported a position in IMMU in Q2 2013 and held it in 26 quarters. The position peaked at $213M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citadel Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citadel Advisors sold 2,506,602 Immunomedics Inc shares in Q4 2020, an estimated $213M.
- Citadel Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 26 quarters.
- Citadel Advisors's Immunomedics Inc position peaked at $213M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.